CSL NEW ZEALAND Prothrombinex-VF Human Prothrombin Complex 500 IU Powder for injection

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

Factor IX, Quantity: 500 IU; Factor X, Quantity: 500 IU; Factor II, Quantity: 500 IU

Dostupné s:

CSL Behring Australia Pty Ltd

INN (Mezinárodní Name):

Factor II,Factor IX,Factor X

Léková forma:

Injection, diluent for

Složení:

Excipient Ingredients: water for injections

Podání:

Intravenous

Jednotky v balení:

500 IU

Druh předpisu:

(S1) This Schedule is intentionally blank

Terapeutické indikace:

Prothrombinex-VF is indicated in the prophylaxis and treatment of bleeding in patients with single or multiple congenital deficiency of factor IX, II or X and in patients with single or multiple acquired prothrombin complex factor deficiency requiring partial or complete reversal (e.g. reversal of warfarin anti-coagulant therapy). Because of the potential risk of Prothrombinex-VF induced thrombosis, Prothrombinex-VF should not be used for prophylaxis or treatment of haemorrhage in patients with haemophilia B if a highly-purified factor IX preparation is available.

Přehled produktů:

Visual Identification: Clear colourless solution, free from visible particles; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Stav Autorizace:

Licence status A

Datum autorizace:

2000-03-02